SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This ...

In a tough fundraising space, cell therapy biotechs pursuing autoimmune indications review staffing to ensure the right ...

In this GEN webinar, our speakers will present important considerations for quality control testing for biosafety and product ...

In vivo cell therapy is a new way of delivering cell therapy, but the actual therapies don’t need to be new. In theory, ...

When translating your process into a GMP-compliant manufacturing protocol, it’s important to understand all the critical steps.

UC San Francisco treated its first brain cancer patient with an experimental new CAR-T therapy discovered and manufactured at ...

Stem cells grown in microgravity aboard the International Space Station (ISS) have unique qualities that could one day help ...

The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of ...

Stem cell therapy is emerging as a promising and effective treatment for neurodegenerative diseases. Popular as Lou Gehrig’s ...

ImmunityBio has around $130.1 million in cash, enough to fund operations for at least the next 12 months. Read why I'm very ...

Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.

引言2024年10月23日，西奈山伊坎医学院时毅、Adolfo García-Sastre、Kris M. White和牛津大学章培君合作（第一作者为向宇菲）在Cell上发表了文章Adaptive Multi-Epitope Targeting ...